Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

“…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD_EROD,28dph of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD_length,28dph of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …”

(a) Histogram of relative phase at all steps for all participants. by Shinnosuke Hase (20917896)

BFD2 aggravates the inflammatory response to <i>Toxoplasma gondii</i> infection. by Xiaocheng Zhang (3140460)

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Conceptual framework to guide the study. by Resham B. Khatri (10949429)

“…From 2011 to 2022, there were increased institutional deliveries overall (47% to 81%) and CS within private HFs (30% to 51%), alongside a decreasing trend in the utilization of maternity incentives (87% to 78%). …”

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

“…</p><p>Conclusions</p><p>In comparison with XRT, PT can reduce most side effects, without significantly decreasing the survival rate. <b>T</b>here is considerable clinical relevance in the findings, even not all of them are statistically significant, which may facilitate the development of protocols regarding the usage of radiotherapy methods, and may encourage the establishment of more proton centers, where more studies can be done.…”

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…</p><p>Conclusions</p><p>In comparison with XRT, PT can reduce most side effects, without significantly decreasing the survival rate. <b>T</b>here is considerable clinical relevance in the findings, even not all of them are statistically significant, which may facilitate the development of protocols regarding the usage of radiotherapy methods, and may encourage the establishment of more proton centers, where more studies can be done.…”

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…</p><p>Conclusions</p><p>In comparison with XRT, PT can reduce most side effects, without significantly decreasing the survival rate. <b>T</b>here is considerable clinical relevance in the findings, even not all of them are statistically significant, which may facilitate the development of protocols regarding the usage of radiotherapy methods, and may encourage the establishment of more proton centers, where more studies can be done.…”

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... by Amoura M. Abou-El-Naga (21001524)

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). by Amoura M. Abou-El-Naga (21001524)

The prevalence and absolute counts of peripheral blood Lymphocyte subsets. by Songyan Zou (11399489)

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

BFD2 regulates anxiety-like behaviors induced by acute-stage <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

BFD2 impacts pre-anxiety-like behaviors in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

BFD2 exacerbates the inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)